2,8-Dimethyl-4H-pyrido[1,2-a]pyrimidin-4-one, 250mg

((S)-1-((S)-1-Phenylethyl)pyrrolidin-3-yl)methanol, 95.0%, 100mg

(R)-2-Phenyl-2,3-dihydrobenzo[d]imidazo[2,1-b]thiazole, 97%, 1g

4-(3,4-dimethylphenyl)-6-(3,4,5-trimethoxyphenyl)pyrimidin-2-amine, 95.0%, 10g

5-(4-Bromo-phenyl)-3-methyl-isoxazole-4-carboxylic acid, 95.0%, 25g

(E)-But-2-ene-1,4-diamine dihydrochloride, 97%, 5g

(1R,2R)-N1,N1,N2,N2-tetramethylcyclohexane-1,2-diamine, 95.0%, 25g

OAC1>98.0%(GC)10mg

Ethyl 3-[6-(dimethylamino)-4-(trifluoromethyl)pyridin-2-yl]benzoate, 95.0%, 1g

5-Amino-3-methylisoxazole, 98.0%, 1g

5-Boc-Octahydropyrrolo[3,4-c]pyridine, 95.0%, 100mg

Polyethylene Glycol Dimethacrylate (n=approx. 9) (stabilized with MEHQ)25g

3-Methyl-5-nitrobenzaldehyde, 95.0%, 250mg